| |
| |
|
| Insider
Information: |
Evans John M. |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,058,343 |
|
|
Indirect Shares
|
103,000 |
|
|
| Direct
Value |
$25,495,483 |
|
|
|
Indirect Value
|
$2,481,270 |
|
|
| Total
Shares |
1,161,343 |
|
|
| Total
Value |
$27,976,753 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Beam Therapeutics Inc. |
BEAM |
|
2024-04-01 |
1,058,343 |
2024-04-01 |
103,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BEAM |
Beam Therapeutics Inc. |
CEO |
• • – |
2022-04-28 |
4 |
OE |
$1.03 |
$137,036 |
D/D |
59,450 |
1,148,520 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
CEO |
• • – |
2022-07-28 |
4 |
AS |
$64.87 |
$1,972,523 |
D/D |
(30,000) |
1,088,520 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
CEO |
• • – |
2022-07-28 |
4 |
AS |
$64.88 |
$1,315,559 |
I/I |
(20,000) |
123,000 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
CEO |
• • – |
2022-10-31 |
4 |
AS |
$44.92 |
$1,389,225 |
D/D |
(30,000) |
1,058,520 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
CEO |
• • – |
2022-10-31 |
4 |
AS |
$44.93 |
$927,203 |
I/I |
(20,000) |
103,000 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
CEO |
• • – |
2023-04-03 |
4 |
AS |
$30.31 |
$156,430 |
D/D |
(5,161) |
1,124,472 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
CEO |
• • – |
2023-04-04 |
4 |
AS |
$29.09 |
$188,904 |
D/D |
(6,493) |
1,117,979 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
CEO |
• • – |
2024-01-31 |
4 |
AS |
$25.33 |
$1,519,800 |
D/D |
(60,000) |
1,058,262 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
CEO |
• • – |
2024-03-28 |
4 |
AS |
$33.86 |
$2,031,402 |
D/D |
(60,000) |
998,262 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
CEO |
• • – |
2024-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
77,500 |
1,076,445 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
CEO |
• • – |
2024-04-01 |
4 |
AS |
$32.13 |
$581,617 |
D/D |
(18,102) |
1,058,343 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
CEOOfficer |
• • – |
2020-02-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
878,257 |
|
- |
|
| BEAM |
Beam Therapeutics Inc. |
CEOOfficer |
• • – |
2020-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
223,000 |
|
- |
|
38 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
